Home Finance Medicare to Pay for Biogen's New Alzheimer's Drug in Clinical-Trial Patients

Medicare to Pay for Biogen's New Alzheimer's Drug in Clinical-Trial Patients

The Centers for Medicare and Medicaid Services said it will cover the cost of the drug Aduhelm, but as part of further clinical testing.

Source link – Read full article

- Advertisement -
- Advertisment -

READ THIS LIST